We are live on ! Find out more
KALA icon

KALA BIO
KALA

99 hedge funds and large institutions have $79.4M invested in KALA BIO in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

17% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 23

2% more funds holding

Funds holding: 97 → 99 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% less ownership

Funds ownership: 0.02% → 0.02% (-0%)

54% less capital invested

Capital invested by funds: $171M → $79.4M (-$91.6M)

57% less call options, than puts

Call options by funds: $388K | Put options by funds: $907K

Holders
99
Holders Change
+2
Holders Change %
+2.06%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
27
Reduced
23
Closed
13
Calls
$388K
Puts
$907K
Net Calls
-$519K
Net Calls Change
-$1.5M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$1M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$621K
3
Renaissance Technologies
Renaissance Technologies
New York
+$578K
4
Millennium Management
Millennium Management
New York
+$432K
5
TCM
Towercrest Capital Management
Pennsylvania
+$423K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$7M
2
UBS Group
UBS Group
Switzerland
-$1.16M
3
Deutsche Bank
Deutsche Bank
Germany
-$1.04M
4
JAM
Jupiter Asset Management
United Kingdom
-$920K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$863K
Name Holding Trade Value Shares
Change 		Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$70K – – –
AIG
52
American International Group
New York
$69K – – –
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$68K +$77.7K +9 New
GCP
54
GSA Capital Partners
United Kingdom
$66K +$86.3K +10 New
SG Americas Securities
55
SG Americas Securities
New York
$66K +$86.3K +10 New
VRS
56
Virginia Retirement Systems
Virginia
$66K +$86.3K +10 New
Rafferty Asset Management
57
Rafferty Asset Management
New York
$64K +$86.3K +10 New
AG
58
Algert Global
California
$62K -$173K -20 -69%
Invesco
59
Invesco
Georgia
$58K +$8.63K +1 +13%
DekaBank Deutsche Girozentrale
60
DekaBank Deutsche Girozentrale
Germany
$55K – – –
CPIG
61
Chicago Partners Investment Group
Illinois
$55K +$34.5K +4 +57%
ProShare Advisors
62
ProShare Advisors
Maryland
$53K -$17.3K -2 -20%
DTL
63
Dynamic Technology Lab
Singapore
$53K +$8.63K +1 +14%
Group One Trading
64
Group One Trading
Illinois
$53K +$8.63K +1 +14%
CAG
65
Csenge Advisory Group
Florida
$53K +$69K +8 New
CLOS
66
Compagnie Lombard Odier SCmA
Switzerland
$52K – – –
VOYA Investment Management
67
VOYA Investment Management
Georgia
$52K – – –
Macquarie Group
68
Macquarie Group
Australia
$51K +$69K +8 New
CS
69
Credit Suisse
Switzerland
$49K -$8.63K -1 -13%
LPL Financial
70
LPL Financial
California
$46K +$60.4K +7 New
SCM
71
Symons Capital Management
Pennsylvania
$37K – – –
Osaic Holdings
72
Osaic Holdings
Arizona
$37K +$17.3K +2 +50%
NFSG
73
Newbridge Financial Services Group
Florida
$37K +$51.8K +6 New
Commonwealth Equity Services
74
Commonwealth Equity Services
Massachusetts
$34K -$8.63K -1 -17%
AWA
75
Artemis Wealth Advisors
New York
$33.9K – – –
1 2
3
4 5

KALA Hedge Fund Activity: Q3 2021 in Review

99 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q3 2021, worth a combined $79.4M — down 54% from $171M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new KALA positions and 13 closed out — a net gain of 3 holders — while 27 added to existing stakes and 23 trimmed.

The largest buyer was State Street, adding an estimated $1M. The largest seller was OrbiMed, cutting an estimated $7M.

  • 99 institutional investors held KALA BIO (KALA) as of Q3 2021, up from 97 in Q2 2021.
  • Funds reported $79.4M of KALA BIO stock for Q3 2021, down 54% quarter-over-quarter.
  • 16 funds opened new KALA BIO positions in Q3 2021 and 13 closed out, a net change of +3 holders.
  • The largest KALA BIO buyer in Q3 2021 was State Street, an estimated $1M added.
  • The largest KALA BIO seller in Q3 2021 was OrbiMed, an estimated $7M sold.

Based on aggregated 13F filings for Q3 2021.